AUM Biosciences

Singapore, Singapore

AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.

$27.0M raised

Oct 2021

Series A

Biotechnology Oncology

Top Investors

Agency for Science Technology and Research SPRIM Everlife

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AUM Biosciences

How much funding has AUM Biosciences raised?

AUM Biosciences has raised $27.0M in total funding. The most recent round was Series A. The last funding was announced in October 2021.

Who are AUM Biosciences's investors?

AUM Biosciences's investors include Agency for Science, Technology and Research, SPRIM, Everlife.

Where is AUM Biosciences headquartered?

AUM Biosciences is headquartered in Singapore, Singapore.

What does AUM Biosciences do?

AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.

What stage is AUM Biosciences at?

AUM Biosciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 12, 2021.

MLA

"AUM Biosciences — Funding & Investors." VCBacked, October 12, 2021, https://www.vcbacked.co/company/aum-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2021). AUM Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/aum-biosciences

Wikipedia (cite web)

{{cite web |title=AUM Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/aum-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 12, 2021.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K